Provider of organ perfusion services intended to serve the people of Canada. The company's service helps to restore the function of donor organs, enabling people to get a new life.

A modern, upscale Mexican restaurant coming soon to Washington, D.C.

Telefónica is a leading multinational telecommunications company headquartered in Madrid, Spain, and one of the largest service operators globally by market capitalization and number of customers. The company provides a comprehensive range of services, including fixed and mobile telephony, high-speed broadband, and pay television. Operating primarily across Europe and Latin America, Telefónica manages its portfolio through globally recognized premium brands such as Movistar (in Spain and Latin America), O2 (in the UK and Germany), and Vivo (in Brazil). At the core of its strategy, Telefónica is driving a profound digital transformation centered on providing excellent connectivity through the continuous development of next-generation networks, including extensive fiber optic (FTTH) and 5G deployments. Beyond connectivity, the company has a strong focus on new digital services. Through its Telefónica Tech division, it offers a powerful suite of integrated solutions for B2B clients in high-growth areas, including Cybersecurity, Cloud, IoT, and Big Data. Telefónica is also at the forefront of open innovation through Wayra, its corporate venture capital (CVC) arm. Wayra invests in and scales disruptive technology startups across the globe, integrating them into Telefónica's ecosystem to foster innovation and develop new business opportunities. As a publicly-traded company, Telefónica is committed to generating sustainable value for its stakeholders and empowering digital inclusion with a mission to ''make our world more human by connecting people's lives.''

As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-on approach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.

ODN Europe is a regional chapter of the Organization Development Network that supports professionals in the field of organizational development. The group provides events, workshops, and resources to facilitate learning and collaboration. It serves as a platform for sharing practices, research, and insights related to organizational change. ODN Europe engages members through professional development and networking opportunities.

mybacs is a research-driven DTC company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.

Speedinvest is one of Europe’s most active early-stage venture capital funds, with more than €1.2bn in AuM and offices in Berlin, London, Munich, Paris, and Vienna. Our dedicated sector-focused teams (Climate Tech & Industrial Tech, Deep Tech, Fintech, Health & Bio, Marketplaces & Consumer Tech, SaaS & Infra) are the first to fund EMEA's most innovative pre-Seed and Seed tech startups. Our in-house operational experts and global network of industry leaders support our portfolio companies with growth, people (HR), market expansion, and more throughout every stage of their journeys. Bitpanda, GoStudent, Wayflyer, Open, CoachHub, Schüttflix, TourRadar, Adverity, and TWAICE are among our portfolio of 400+ companies.

Savana is a software company building financial software solutions for fintech companies. The company's solution allows financial institutions to modernize their siloed and dated systems with minimal disruption, less development time, and reduced costs. The omnichannel customer and account servicing solution helps financial institution serve their customers better, offering a unified digital experience while creating operational efficiencies through automation of processes. Savana ''nGage'' Platform is the common core of all nGage financial software solutions. The nGage solutions suite provides a transformational technology platform for banks and mortgage lenders that wish to add efficiency, volume, and profitability to their operations. Its process management capabilities make it a flexible tool that is configurable to meet the individual needs of Savana’s banking, payments, and mortgage customers.

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

S3 Connected Health helps you leverage digital technologies to make a real difference to healthcare outcomes. S3 Connected Health breadth of experience across therapy areas, technologies and territories means they can truly be your global partner delivering scalable solutions that make a difference.

Invest Cyprus is a non-profit national body and the government’s dedicated partner responsible for the facilitation of investments into Cyprus. In close collaboration with all government authorities, public institutions as well as the private sector and international experts, Invest Cyprus is the investor’s single point of contact.

Dieter von Holtzbrinck Ventures (DvH Ventures) is one of the leading European early-stage investors. As an independent venture capitalist, DvH Ventures invests in young technology companies, building successful investment clusters in areas such as digital health, education and fintech. In addition to capital, DvH Ventures supports companies with management expertise and an international investor network. An exclusive media-for-equity program also offers access to strong brands such as Handelsblatt, DIE ZEIT, WirtschaftsWoche and Apotheken Umschau, and thus an enormous reach into the respective target groups. DvH Ventures was founded in 2014 and today manages various venture capital funds from its offices in Cologne and Vienna. Managing partners are Peter Richarz and Fabian von Trotha.

Sopharma is engaged in the production and trade of medical substances and finished drug forms. The company is focused on cardiology, gastroenterology, pain management cough and cold, immunology and dermatology, respiratory and asthma, neurology and psychiatry, urology and gynecology.

Dieter von Holtzbrinck Ventures (DvH Ventures) is one of the leading European early-stage investors. As an independent venture capitalist, DvH Ventures invests in young technology companies, building successful investment clusters in areas such as digital health, education and fintech. In addition to capital, DvH Ventures supports companies with management expertise and an international investor network. An exclusive media-for-equity program also offers access to strong brands such as Handelsblatt, DIE ZEIT, WirtschaftsWoche and Apotheken Umschau, and thus an enormous reach into the respective target groups. DvH Ventures was founded in 2014 and today manages various venture capital funds from its offices in Cologne and Vienna. Managing partners are Peter Richarz and Fabian von Trotha.

Mercia Asset Management invest across four distinct asset classes of venture, private equity and debt, referred to as our ‘Complete Capital Solution.Mercia Asset Management ision is to be the first choice for investors, investees and employees and, by aspiring to be the first choice, we believe that Mercia will deliver superior returns for business owners, shareholders and fund investors alike.

Oncology Ventures will make investments in cancer-focused data, infrastructure, IT, and services start-ups with the goal of fundamentally changing the way cancer treatment is conceived and provided at scale. Our fund will not invest in pharmaceuticals, therapies, or medical devices.

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is done through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Developer of healthcare software designed to save and improve lives. The company's software uses digital innovation to accelerate the development of healthcare cures and the discovery of treatments, enabling clients to improve the quality of life.

Provider of SAP services in Poland, designed to enhance business efficiency and system integration. The company specializes in SAP system implementations, managed services, user support, and system customization, serving various industries in the region. Their expertise encompasses ERP implementations, HR system development, IT security audits, hybrid cloud solutions, software development, and process digitalization. Established in 1995, the company has a long history of supporting clients in optimizing their operations and technology.

Kiffik developed a novel technology that allows completely non-invasive access to an interstitial fluid that fits in a wearable, connected device capable of transmitting health data from nearly anywhere in the world. Kiffik Biomedical receives GHP Biotechnology award for its remarkable wearable device that offers continuous access to interstitial fluid in humans and animals.

Coloplast provides skin care, interventional urology, voice, and respiratory care services. Ostomy care products include new sensura mio, sensura, and brava ostomy accessories. Continence includes catheters, transanal irrigation system, urisheaths, and urine bags. Wound care products include biatain silicone, biatain silicone ag, and comfeel plus. Skin care products includes interdry, cleansers, moisturisers, skin protectants, antifungals, hand cleanser, and odour control.

CHI Software is a global technological leader shaping the future through innovation and delighting clients for over 16 years. We've partnered with hundreds of startups and enterprise companies to empower them with our engineering capabilities and provide unmatched guidance, to accelerate strategically from idea to finished product. Our talented team of software developers, business analysts, architects, and UI/UX designers is passionate about Cloud Computing, Big Data, Artificial Intelligence, and IoT. CHI's success comes from care, we love working with our clients worldwide to overcome challenges, to create comprehensive solutions, and to deliver exceptional products.

The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities. Encompassing the Icahn School of Medicine at Mount Sinai and seven hospital campuses in the New York metropolitan area, as well as a large, regional ambulatory footprint, Mount Sinai is internationally acclaimed for its excellence in research, patient care, and education across a range of specialties. The Mount Sinai Health System was created from the combination of the Mount Sinai Medical Center and Continuum Health Partners, which both agreed unanimously to combine the two entities in July 2013. The Health System is designed to increase efficiencies and economies of scale; improve quality and outcomes; and expand access to advanced primary, specialty, and ambulatory care services throughout a wide clinical network. The Health System includes more than 7,000 primary and specialty care physicians and 12 minority-owned free-standing ambulatory surgery centers. Mount Sinai also features a robust and continually expanding network of multispecialty services, including more than 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island. It has more than 40 clinical and academic relationships with other local health care organizations. Mount Sinai physicians can be found in more than 300 community locations throughout the New York metropolitan area. With an extraordinary array of resources for the provision of compassionate, state-of-the-art care, the Mount Sinai Health System is poised to identify and respond to the health-related needs of the diverse populations they serve.

DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior. DeepLife is a biotech company with a mission to build the next generation of system biology. The company works in a highly collaborative translational manner, to facilitate the transition of discoveries from the laboratory to patients. The company operates through collaboration with academic groups in their respective areas of expertise.

Operator of a Federally Qualified Health Center (FQHC) providing integrated health care services. The nonprofit organization offers medical, dental, pharmacy, behavioral health, and pediatric care services, serving communities across Colorado through clinic locations, school-based sites, and a mobile unit. It accepts multiple insurance types and uses a sliding fee scale based on income and family size. Accredited by AAAHC and designated as a Patient Care Medical Home.